Figure 2.

Achievement rates of clinical remission and the four criteria. This radar chart is composed of an ACT ≥ 20, no exacerbation, no maintenance OCS, a %FEV₁ ≥ 80 and clinical remission. The analyses were conducted for (A) all patients, bio-naïve (BEN) patients and switching (M-B) patients; (B) patients with a BMI ≥ 25 and patients with a BMI < 25 (kg/m²); (C) patients with an MPR ≥ 80 and patients with an MPR < 80 (%); (D) patients with a disease duration ≥ 20 and patients with a disease duration < 20 (years); (E) ECRS (+) and ECRS (-) patients; (F) patients with a BEC ≥ 300 and patients with a BEC < 300 (/µL); (G) patients with a BBC ≥ 22 and patients with a BBC < 22 (/µL); and (H) patients with FeNO ≥ 50 and patients with FeNO < 50 (ppb).

Abbreviations: ACT, Asthma Control Test; OCS, oral corticosteroid; FEV₁, forced expiratory volume in one second; BEN, benralizumab; M-B, switching from mepolizumab to benralizumab; BMI, body mass index; MPR, medication possession ratio; ECRS, eosinophilic chronic rhinosinusitis; BEC, blood eosinophil count; BBC, blood basophil count; FeNO, fractional exhaled nitric oxide.